Respiratory Syncytial Virus in Older Adults: Understanding Risk, Diagnosis, and Evolving Prevention Strategies

Hear expert insights on risk factors for respiratory syncytial virus among adults, the need for a vaccination strategy in this population, and the evolving clinical studies on vaccines for older adults.

Spencer H. Durham, PharmD, BCPS, BCIDP Stefan Gravenstein, MD, MPH Barbara Resnick, PhD, CRNP Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: July 21, 2021 Expired: No longer available for credit

Overview of RSV Illness in Older Adults

RSV Prevention in Older Adults

Practical Strategies for Increasing Uptake of Immunizations Among Older Adults

Questions and Answers

Learn about risk factors for respiratory syncytial virus among adults, the need for a vaccination strategy in this population, and the evolving clinical studies on vaccine strategies for older adults.

Spencer H. Durham, PharmD, BCPS, BCIDP Stefan Gravenstein, MD, MPH Barbara Resnick, PhD, CRNP Released: June 25, 2021

There is a growing recognition of the effects of RSV among older adults, particularly those in long-term care facilities. Here’s my take on how preventing transmission can save millions in healthcare costs.

Elliott Bosco, PharmD, PhD Released: August 11, 2021

Vaccines are at the forefront of the national consciousness, and manufacturers of the highly effective COVID-19 vaccines have entered the race to find an effective RSV vaccine.

Spencer H. Durham, PharmD, BCPS, BCIDP Released: October 28, 2021

The potential availability of an effective RSV vaccine for older individuals is on the horizon, and with it comes numerous ways to address vaccine hesitancy in this patient population.

Barbara Resnick, PhD, CRNP Released: January 12, 2022

We are closer than ever to finding an effective RSV vaccine, but recent challenges may delay approval.

Angela Branche, MD Released: April 7, 2022

In this on-demand recording of a live webinar, expert faculty discuss risk factors for respiratory syncytial virus among adults, the need for a vaccination strategy in this population, and the evolving clinical studies on vaccines for older adults.

Spencer H. Durham, PharmD, BCPS, BCIDP Stefan Gravenstein, MD, MPH Barbara Resnick, PhD, CRNP Released: July 15, 2021